// App-Quantinova.ai

: Dissecting the Knowns for the Unknowns: Refining the Classification of Genomic Variations in Hematological Diseases By the Clingen Hematological Cancer Taskforce (HCT)

Researchers

Presenter

  • Yuwen Li

Principal Investigators

  • Nathan Kopp

  • Coumarane Mani

  • Heather E Williams

  • Wenying Zhang

  • Jianhua Zhao

  • Kilannin Krysiak

  • Arpad Danos

  • Xiangqiang Shao

  • Rong He

  • Panieh Terraf

  • Nikita N Mehta

  • Shivani Golem

  • Jie Liu

  • Destiney Allen

  • Chimene Kesserwan

  • Hagop Kantarjian

  • Torsten Haferlach

  • Piers Blombery

  • Madhu M Ouseph

  • Ella Thompson

  • Yiming Zhong

  • Xiaonan Zhao

  • Yasmina Jaufeerally Fakim

  • Sheeja T Pullarkat

  • Obi L. Griffith

  • Malachi Griffith

  • Rashmi Kanagal-Shamanna

  • Xinjie Xu

Medical Centers

  • MLL Munich Leukemia Laboratory, Munich, Germany

  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York

  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles

  • University of Kansas Medical Center, Kansas City

  • Department of Pathology, Memorial Sloan Kettering Cancer Center, NEW YORK, NY

  • National Cancer Institute, Bethesda

  • Department of Medicine, Washington University School of Medicine, St. Louis, MO

  • University of Mauritius, Réduit, Mauritius

  • Peter MacCallum Cancer Centre, Peter Maccallum Cancer Centre, East Melbourne, Australia

  • Cincinnati Children's Hospital Medical Center, Division of Human Genetics, Department of Pediatrics, University of Cincinnati, Cincinnati, OH

  • ARUP Laboratories, University of Utah, Salt Lake City, UT

  • Quest Diagnostics, Secaucus

  • Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX

  • David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA

  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX

  • Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia

  • Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

  • Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

  • Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI

  • Memorial Sloan Kettering Cancer Center, New York

  • Hayward Genetics Center, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA

  • Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO

  • Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • Germany

  • United States

  • Mauritius

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • Hematocrit

Drug/Treatment

  • gilteritinib

  • Midostaurin

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Adaptive

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved